Rafferty Asset Management, LLC Alkermes Plc. Transaction History
Rafferty Asset Management, LLC
- $22.9 Billion
- Q1 2025
A detailed history of Rafferty Asset Management, LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 150,448 shares of ALKS stock, worth $4.2 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
150,448
Previous 209,580
28.21%
Holding current value
$4.2 Million
Previous $6.03 Million
17.59%
% of portfolio
0.02%
Previous 0.02%
Shares
25 transactions
Others Institutions Holding ALKS
# of Institutions
403Shares Held
176MCall Options Held
229KPut Options Held
436K-
Black Rock Inc. New York, NY29.1MShares$813 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$509 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11.8MShares$329 Million0.05% of portfolio
-
State Street Corp Boston, MA8.02MShares$224 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY6.88MShares$192 Million3.72% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $4.59B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...